Answer

No, you should not take Dong Quai with theophylline without close medical supervision. This combination carries a critical risk of increasing theophylline levels in the blood, which can lead to toxicity.

Evidence Assessment

Quality Score: 35/100 (Tier D - Preliminary/Weak Evidence) The evidence for this interaction is based on pharmacological profiling (CYP450 enzyme inhibition) rather than randomized controlled trials or published case reports. While the biochemical mechanism is plausible, clinical data on this specific pair is limited.

Clinical Evidence

The interaction is driven by the effect of Dong Quai on the cytochrome P450 enzyme system. Specifically, Dong Quai acts as a weak inhibitor of CYP3A4 [Flockhart CYP450 Table]. Theophylline is a substrate of the CYP450 system; when its metabolism is inhibited, the drug remains in the plasma for longer periods and reaches higher concentrations.

Because theophylline has a narrow therapeutic index—meaning the difference between a therapeutic dose and a toxic dose is small—even a weak inhibition of its metabolism can lead to clinically significant toxicity. Symptoms of theophylline toxicity may include nausea, vomiting, insomnia, tremors, and in severe cases, cardiac arrhythmias or seizures.

Practical Guidance

Due to the critical nature of this interaction, the following is advised: * Avoidance: It is generally recommended to avoid Dong Quai while taking theophylline. * Monitoring: If the combination is deemed necessary by a provider, frequent monitoring of serum theophylline levels is required. * Dose Adjustment: A reduction in the theophylline dose may be necessary to maintain levels within the safe therapeutic range.

Safety & Interactions

Contraindication: Caution/Avoid * Drug Class: Methylxanthine (Bronchodilator). * Mechanism: Inhibition of CYP3A4, leading to decreased clearance of theophylline and increased plasma concentrations. * Clinical Management: Monitor for signs of theophylline toxicity (tachycardia, restlessness, nausea). If these occur, the supplement should be discontinued immediately. * High-Risk Populations: * Elderly: Increased risk due to naturally declining hepatic clearance. * Liver Disease: Patients with impaired liver function are at a significantly higher risk of toxicity. * Cardiac Patients: Those with pre-existing arrhythmias should be extremely cautious as theophylline toxicity can trigger cardiac events.